Satellite™ PEEK Nucleus Replacement Retrospective Analysis
1 other identifier
observational
40
3 countries
3
Brief Summary
The Satellite™ Retrospective Analysis is an international, retrospective, multi-center, non-interventional post-marketing study designed to document and analyze existing data with the device in a "real-world" setting. The purpose of this study is to evaluate number of adverse device effects (ADEs), serious adverse device effects (SADEs) and serious adverse event (SAEs) and early clinical effectiveness for the Satellite™ Nucleus Replacement in a standard clinical practice. Data collection will include information on health related quality of life (QoL), physical functioning and adverse event after nucleus replacement surgery. Radiographic measures will also be assessed to evaluate changes in disc height at the operated level and changes in segmental range of motion. All patients who were implanted with a Satellite™ Nucleus Replacement Prosthesis in the participating sites are eligible for participation in the Satellite ™ Retrospective Analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2010
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 15, 2010
CompletedFirst Posted
Study publicly available on registry
April 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedResults Posted
Study results publicly available
August 7, 2014
CompletedJanuary 28, 2016
January 1, 2016
1.5 years
April 15, 2010
May 13, 2014
January 26, 2016
Conditions
Outcome Measures
Primary Outcomes (4)
Health-related Quality of Life Using the Visual Analogue Scale for Back Pain
The Visual Analogue Scale (VAS) is a tool widely used to measure pain. It is a 10 cm scale, 0cm means 'no pain' and 10cm means 'worst possible pain'. The patients mark the location corresponding to the amount of back pain they experienced on the 10cm line.
Up to 12 months follow up visit
Health-related Quality of Life Using the Visual Analogue Scale for Leg Pain
The Visual Analogue Scale (VAS) is a tool widely used to measure pain. It is a 10 cm scale, 0cm means 'no pain' and 10cm means 'worst possible pain'. The patients mark the location corresponding to the amount of back pain they experienced on the 10cm line.
Up to 12 months follow up visit
Physical Functioning Using the Oswestry Disability Index (ODI)
The Oswestry Disability Index (ODI) derives from the Oswestry Low Back Pain Questionnaire, it is used to measure disability for low back pain. The index is scored from 0 to 50; 0 meaning 'no disability' and 50 meaning 'maximum disability'.
Up to 12 months follow up visit
Safety by Evaluating the Number of Serious Adverse Device Effects (SADEs), Adverse Device Effects (ADEs) and Serious Adverse Events (SAEs)
Patients were followed up according to the local practice, up to 1 year
Secondary Outcomes (4)
Range of Motion (ROM) at Implanted Level
Up to 12 months follow up visit
Intervertebral Disc Space (IVD) at Implanted Level
Up to 12 months follow up visit
Device Subsidence Measured as Interbody Height Ratio (IBHR)
Up to 12 months follow up visit
Changes in Device Placement
Up to 12 months follow up visit
Eligibility Criteria
All patients who were implanted with a Satellite™ Nucleus Replacement device at the participating sites are eligible for participation in the Satellite ™ Retrospective Analysis.
You may qualify if:
- Patient must have signed a Patient Data Release Form
- Age of at least 18 years and skeletally mature at the time of surgery
- Patient has not reached the age of legal consent according to local laws
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Masaryk Hospital
Ústí nad Labem, Czechia
ÚVN SNP
Ružomberok, Slovakia
Instituto de Columna de Caracas
Caracas, Venezuela
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Due to the retrospective design, it was not possible to report on SF-36 results and Modic endplate changes results as limited data was available in the patient records.
Results Point of Contact
- Title
- Cristina Faria
- Organization
- Medtronic Spinal & Biologics
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2010
First Posted
April 27, 2010
Study Start
April 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
January 28, 2016
Results First Posted
August 7, 2014
Record last verified: 2016-01